CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale Director sold 5,721 shares at an average $16.81 ($96,148)
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief R&D Officer sold 31,111 shares at $18.30 ($569,331)
- 4 Open-market sale SVP & General Counsel sold 1,917 shares at $18.30 ($35,081)
- 4 Open-market sale SVP & Chief Accounting Officer sold 13,391 shares at $18.30 ($245,055)
- 4 Open-market sale President & CEO sold 11,560 shares at $18.30 ($211,548)
- 4 Open-market sale SVP & Chief Commercial Officer sold 6,085 shares at $18.30 ($111,356)
- 4 Open-market sale SVP, COO & CFO sold 7,898 shares at $18.30 ($144,533)
- 4 Open-market sale Director sold 8,000 shares at $19.34 ($154,720)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Director sold 8,000 shares at $18.98 ($151,840)
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief R&D Officer sold 24,141 shares at $22.37 ($540,034)
- 4 Open-market sale SVP & General Counsel sold 2,173 shares at $22.37 ($48,610)
- 4 Open-market sale SVP & Chief Accounting Officer sold 11,705 shares at $22.37 ($261,841)
Page 22 of 100 · 1,982 filings